Otsuka defence threatened in Abilify patent case
Allens 2018-11-05 9:03 pm By Miklos Bolza | Sydney
Please login to bookmark Close

The Commonwealth of Australia is weighing a bid to strike out Otsuka Pharmaceutical’s defence as the government seeks lost subsidies after an almost seven-year long patent dispute over the antipsychotic drug, Abilify.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au